The hidden health risks of vaping cannabis and nicotine

E-cigarettes and vaping devices have been widely marketed as a safer alternative to traditional cigarettes, but emerging research paints a more concerning picture, especially for users who vape cannabis. While e-liquids typically contain propylene glycol, vegetable glycerin, and nicotine, many also include tetrahydrocannabinol (THC) and other additives. When heated, these ingredients produce harmful chemicals such as reactive aldehydes and other toxins that can trigger inflammation and long-term health damage. Studies demonstrate that vaping correlates with increased oxidative stress, inflammation, and endothelial damage—effects comparable to traditional tobacco smoking, contradicting the widespread belief that vaping is inherently safer.

The 2019-2020 e-cigarette or vaping-associated lung injury (EVALI) outbreak serves as a critical cautionary tale, as it was strongly linked to unregulated THC products and vitamin E acetate contamination. This public health crisis highlighted the serious risks posed by uncontrolled manufacturing standards in the vaping industry. For cannabis consumers specifically, these findings underscore the importance of sourcing regulated, tested products and understanding that the delivery method—not just the substance—carries significant health implications.

The research challenges the popular narrative that vaping is a "safer" option and emphasizes that both the cardiovascular and pulmonary systems face genuine risks from inhaling heated e-liquid aerosols. This has important implications for cannabis users who may have switched to vaping as a harm reduction strategy, suggesting that while vaping may reduce certain tobacco-related risks, it introduces its own distinct health concerns that merit serious consideration.